Top 5 Stocks to Buy Now
→ China can’t stop buying gold. Here’s why that matters (From Traders Agency) (Ad)tc pixel Free ANIP Stock Alerts

ANI Pharmaceuticals (ANIP) Short Interest Ratio & Short Volume

ANI Pharmaceuticals logo
$79.49 -1.03 (-1.28%)
Closing price 04:00 PM Eastern
Extended Trading
$79.46 -0.02 (-0.03%)
As of 04:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

ANI Pharmaceuticals Short Interest Overview

As of May 29, 2026, ANI Pharmaceuticals (ANIP) had a short interest of 3.32 million shares sold short, representing 15.90% of the public float. This marks a -8.21% decrease in short interest since the prior report. The short interest ratio (days to cover) is 9.9, meaning it would take 9.9 days of the average trading volume of 391,135 shares to cover all short positions.

Current Short Interest
3,324,397 shares
Previous Short Interest
3,621,862 shares
Change Vs. Previous Month
-8.21%
Dollar Volume Sold Short
$261.00 million
Short Interest Ratio
9.9 Days to Cover
Last Record Date
May 29, 2026
Outstanding Shares
22,745,000 shares
Short Percent of Float
15.90%
Today's Trading Volume
351,433 shares
Average Trading Volume
391,135 shares
Today's Volume Vs. Average
90%
Short Selling ANI Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for ANI Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ANIP Short Interest Over Time

ANIP Days to Cover Over Time

ANIP Percentage of Float Shorted Over Time

ANI Pharmaceuticals Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/29/20263,324,397 shares $261.00 million -8.2%15.9%9.88 $78.51
5/15/20263,621,862 shares $282.54 million +1.7%17.3%7.71 $78.01
4/30/20263,562,734 shares $283.06 million +2.0%17.3%12.96 $79.45
4/15/20263,491,485 shares $267.03 million -2.6%16.7%8.82 $76.48
3/31/20263,584,301 shares $275.63 million -0.5%17.1%12.02 $76.90
3/13/20263,603,758 shares $254.03 million +2.2%18.4%7.89 $70.49
2/27/20263,527,857 shares $260.71 million +2.8%18.0%11.98 $73.90
2/13/20263,430,732 shares $265.40 million -1.2%17.5%10.16 $77.36
1/30/20263,473,308 shares $284.29 million +18.0%17.7%6.98 $81.85
1/15/20262,944,314 shares $251.12 million -0.6%15.0%4.73 $85.29
12/31/20252,962,977 shares $233.90 million +11.0%15.1%6.93 $78.94
12/15/20252,668,488 shares $217.51 million -6.3%13.6%6.85 $81.51
11/28/20252,846,459 shares $241.61 million +14.5%14.5%5.91 $84.88
11/14/20252,485,416 shares $208.82 million -0.8%12.9%5.99 $84.02
10/31/20252,504,638 shares $226.92 million +5.4%13.0%6.34 $90.60
10/15/20252,380,000 shares $214.44 million +2.2%12.6%5.3 $90.10
9/30/20252,330,000 shares $213.43 million +13.7%N/A5 $91.60
9/15/20252,050,000 shares $202.56 million +0.5%N/A4.4 $98.81
8/31/20252,040,000 shares $190.74 million -7.3%10.6%4.5 $93.50
8/15/20252,200,000 shares $192.43 million -0.5%N/A5 $87.47
7/31/20252,210,000 shares $140.00 million +3.8%11.5%5.6 $63.35
7/15/20252,130,000 shares $136.32 million +6.0%N/A6 $64.00
6/30/20252,010,000 shares $131.15 million No Change10.4%5.5 $65.25
6/15/20252,010,000 shares $125.75 million +5.8%10.4%5.2 $62.56
5/31/20251,900,000 shares $112.59 million +2.2%10.3%4.7 $59.26
5/15/20251,860,000 shares $110.73 million -7.0%10.1%4.5 $59.53
4/30/20252,000,000 shares $141.64 million -15.3%N/A5.3 $70.82
4/15/20252,360,000 shares $164.14 million -10.6%12.9%7.7 $69.55
3/31/20252,640,000 shares $176.75 million +2.3%14.4%8.9 $66.95
3/15/20252,580,000 shares $161.22 million +0.8%14.1%9.7 $62.49
2/28/20252,560,000 shares $158.44 million No Change13.9%10.3 $61.89
2/15/20252,560,000 shares $150.84 million +13.3%13.9%11 $58.92
1/31/20252,260,000 shares $132.53 million -1.3%N/A9.1 $58.64
1/15/20252,290,000 shares $129.50 million +6.5%N/A8.9 $56.55
12/31/20242,150,000 shares $118.85 million -8.5%N/A8.5 $55.28
12/15/20242,350,000 shares $132.99 million +27.7%N/A9.3 $56.59
11/30/20241,840,000 shares $105.30 million -12.8%N/A6.3 $57.23
11/15/20242,110,000 shares $119.38 million -2.3%N/A6.7 $56.58
10/31/20242,160,000 shares $123.65 million +5.4%N/A7 $57.25
10/15/20242,050,000 shares $120.13 million -9.7%N/A5.8 $58.60
SpaceX will crumble without these 5 companies (Ad)

The SpaceX IPO is drawing near, but the real opportunity may lie in 5 lesser-known companies providing the critical infrastructure SpaceX depends on to operate. Goldman Sachs and Morgan Stanley are reportedly already building positions in one of these names. Another is a resource miner that Elon Musk's broader empire - including Tesla - relies on. Lance Ippolito has detailed all five inside his free SpaceX Investing Blackbook.tc pixel

Download the free SpaceX Investing Blackbook before these names go mainstream
9/30/20242,270,000 shares $135.43 million +2.3%N/A6.5 $59.66
9/15/20242,220,000 shares $129.89 million -8.3%N/A6.4 $58.51
8/31/20242,420,000 shares $154.28 million +44.9%N/A8.1 $63.75
8/15/20241,670,000 shares $102.04 million +439.8%N/A6.8 $61.10
7/31/2024309,400 shares $20.33 million -20.7%N/A1.3 $65.72
7/15/2024390,000 shares $24.66 million +5.7%N/A2.5 $63.22
6/30/2024369,000 shares $23.50 million -2.0%N/A2.4 $63.68
6/15/2024376,500 shares $23.58 million +11.0%N/A2.5 $62.62
5/31/2024339,100 shares $22.01 million +65.9%N/A2.2 $64.90
5/15/2024204,400 shares $13.25 million -11.1%N/A1.3 $64.82
4/30/2024229,900 shares $15.17 million +7.7%N/A1.6 $66.00
4/15/2024213,500 shares $14.16 million +8.4%N/A1.5 $66.30
3/31/2024197,000 shares $13.62 million -24.7%N/A1.4 $69.13
3/15/2024261,600 shares $17.27 million +5.0%N/A1.9 $66.00
2/29/2024249,100 shares $16.86 million +16.7%N/A1.8 $67.67
2/15/2024213,400 shares $12.28 million -11.9%N/A1.7 $57.55
1/31/2024242,200 shares $13.52 million +8.2%N/A1.6 $55.82
1/15/2024223,900 shares $12.70 million -15.2%N/A1.4 $56.74
12/31/2023264,000 shares $14.56 million -34.0%N/A1.5 $55.14
12/15/2023399,700 shares $21.15 million -0.5%N/A2.3 $52.91
11/30/2023401,700 shares $20.01 million +6.6%N/A2.4 $49.81
11/15/2023376,800 shares $19.71 million -11.0%N/A2.2 $52.30
10/31/2023423,400 shares $26.14 million +1.9%N/A2.2 $61.74
10/15/2023415,400 shares $23.95 million -6.4%N/A2.5 $57.66
9/30/2023444,000 shares $25.78 million +44.9%N/A2.8 $58.06
9/15/2023306,500 shares $19.12 million +15.8%N/A2 $62.39
8/31/2023264,800 shares $17.05 million -7.5%N/A1.7 $64.39
8/15/2023286,200 shares $17.71 million -15.7%N/A2 $61.89
7/31/2023339,300 shares $17.83 million -2.0%N/A2.3 $52.55
7/15/2023346,200 shares $17.41 million +3.8%N/A2.5 $50.28
6/30/2023333,700 shares $17.96 million +21.8%N/A2.5 $53.83
6/15/2023274,000 shares $13.89 million +7.2%N/A2.2 $50.71
5/31/2023255,600 shares $11.54 million -24.1%N/A2.3 $45.14
5/15/2023336,900 shares $13.77 million -15.9%N/A3.2 $40.88
4/30/2023400,700 shares $15.11 million +14.7%N/A5.8 $37.72
4/15/2023349,500 shares $13.43 million +4.7%N/A5.5 $38.42
3/31/2023333,800 shares $13.26 million -3.9%2.6%5.1 $39.72
3/15/2023347,200 shares $13.89 million +15.3%N/A5.1 $40.01
2/28/2023301,100 shares $12.60 million -4.6%N/A4.5 $41.84
2/15/2023315,500 shares $14.21 million -4.3%N/A4.7 $45.04
1/31/2023329,600 shares $14.74 million +1.2%N/A4.5 $44.73
1/15/2023325,700 shares $14.31 million -4.9%N/A4.6 $43.95
12/30/2022342,300 shares $13.77 million -20.0%N/A5 $40.23
12/15/2022427,700 shares $16.78 million -4.3%N/A6.5 $39.24
11/30/2022447,000 shares $18.75 million -11.0%N/A6.7 $41.95
11/15/2022502,200 shares $18.38 million -12.5%4.0%7.5 $36.60
10/31/2022573,700 shares $22.14 million +1.0%4.6%8.8 $38.59
10/15/2022568,000 shares $18.87 million -15.3%4.5%8.4 $33.22
9/30/2022670,700 shares $21.56 million -2.7%5.4%9.1 $32.14
9/15/2022689,200 shares $25.10 million -1.0%5.5%8 $36.42
Trump’s New Dollar revealed (Ad)

The last time something like this happened was 1974 - a secret deal that quietly determined the financial fate of an entire generation. According to Porter Stansberry, founder of one of the largest independent financial research firms in the world, it is happening again. Fortune calls it 'the biggest change to the world's relationship with the dollar' in a generation. Stansberry says Trump's money reset - enacted through executive orders and a treaty signed by 13 nations in December 2025 called Pax Silica - could determine whether you are enriched or quietly impoverished by the shift already underway.tc pixel

Read Porter Stansberry's full briefing and find out which moves to make now
8/31/2022696,200 shares $25.68 million +4.4%5.6%7.6 $36.89
8/15/2022667,100 shares $25.24 million -2.6%5.4%7.1 $37.84
7/31/2022685,000 shares $23.46 million -4.8%7.8%6.6 $34.25
7/15/2022719,400 shares $22.55 million -12.3%8.2%6.5 $31.35
6/30/2022820,000 shares $24.33 million +17.9%9.3%7.3 $29.67
6/15/2022695,400 shares $16.53 million +2.5%7.9%6 $23.77
5/31/2022678,700 shares $20.53 million +6.1%5.5%4.8 $30.25
5/15/2022639,900 shares $16.94 million +9.5%5.2%4.4 $26.47
4/30/2022584,300 shares $17.24 million +9.3%4.7%4.2 $29.51
4/15/2022534,600 shares $17.19 million +4.2%4.3%3.8 $32.16
3/31/2022513,200 shares $14.43 million +65.0%4.2%3.9 $28.11
3/15/2022311,000 shares $9.02 million -12.0%2.5%2.3 $29.01
2/28/2022353,400 shares $13.23 million +8.6%2.9%3.1 $37.45
2/15/2022325,300 shares $13.09 million -8.8%2.7%2.7 $40.25
1/31/2022356,700 shares $14.42 million +22.5%2.9%2.6 $40.42
1/15/2022291,100 shares $12.53 million +13.3%2.4%1.3 $43.03
12/31/2021257,000 shares $11.84 million +3.1%2.1%1.1 $46.08
12/15/2021249,200 shares $11.68 million +15.8%2.1%1.1 $46.86
11/30/2021215,200 shares $8.85 million -7.9%1.9%1.1 $41.14
11/15/2021233,600 shares $10.51 million -53.1%2.1%1.3 $45.01
10/29/2021497,700 shares $18.60 million +4.3%4.5%3 $37.38
10/15/2021477,200 shares $18.39 million -4.9%4.8%8 $38.54
9/30/2021501,900 shares $16.47 million -0.3%5.1%8.5 $32.82
9/15/2021503,200 shares $13.78 million +5.4%5.1%8.3 $27.39
8/31/2021477,300 shares $14.48 million +2.5%4.8%8.1 $30.33
8/13/2021465,600 shares $13.99 million +2.2%4.7%8.1 $30.05
7/30/2021455,400 shares $15.45 million -1.7%4.6%7.5 $33.93
7/15/2021463,300 shares $15.28 million +5.5%4.7%7.9 $32.98
6/30/2021439,300 shares $15.40 million -11.9%4.5%7.4 $35.05

ANIP Short Interest - Frequently Asked Questions

Short interest is the volume of ANI Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 29th, investors have sold 3,324,397 shares of ANIP short. 15.90% of ANI Pharmaceuticals' shares are currently sold short. Learn More on ANI Pharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ANIP shares currently have a short interest ratio of 9.9. Learn More on ANI Pharmaceuticals's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 15.90% of ANI Pharmaceuticals' floating shares are currently sold short.

ANI Pharmaceuticals saw a decline in short interest in May. As of May 29th, there was short interest totaling 3,324,397 shares, a decline of 8.2% from the previous total of 3,621,862 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

15.90% of ANI Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to ANI Pharmaceuticals: ADMA Biologics Inc (8.93%), Annovis Bio, Inc. (18.30%), ImmunityBio, Inc. (41.34%), Nuvalent, Inc. (6.99%), Praxis Precision Medicines, Inc. (13.46%), Vaxcyte, Inc. (10.37%), Lantheus Holdings, Inc. (8.56%), Spyre Therapeutics, Inc. (17.25%), Immunovant, Inc. (9.53%), Protagonist Therapeutics, Inc. (12.15%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($81.27 billion), Invesco QQQ ($49.06 billion), iShares Russell 2000 ETF ($23.61 billion), Western Digital Corporation ($16.93 billion), Sandisk Corporation ($15.61 billion), Salesforce Inc. ($11.65 billion), SPDR S&P Biotech ETF ($10.52 billion), Nebius Group N.V. ($10.24 billion), Lumentum Holdings Inc. ($8.74 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($8.21 billion). View all of the most shorted stocks.

Short selling ANIP is an investing strategy that aims to generate trading profit from ANI Pharmaceuticals as its price is falling. ANIP shares are trading down $1.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for ANI Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ANIP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ANIP, twice per month. The most recent reporting period available is May, 29 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like ANIP:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:ANIP) was last updated on 6/18/2026 by MarketBeat.com Staff.
From Our Partners
China can’t stop buying gold. Here’s why that matters
China has made 18 consecutive months of central bank gold purchases - and analysts believe the official number...
Traders Agency | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
A 3M Oz. Historical Gold Resource And A Market That Hasn't Caught Up
One Canadian junior explorer controls a gold and copper system in British Columbia's Kootenay Golden Arc - a d...
Wall Street Logic | Sponsoredtc pixel
How to play the Biggest IPO in stock market history!
SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insi...
InvestPub | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
DOJ Admits It In Court—Your Cash Can Be Seized Without Warning
The Department of Justice recently argued in court that cash may not be legally your property - raising concer...
Priority Gold | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel